Approach to the Patients with Elevated CA 19-9
Author:
Open Access
- 25 May 2023
- journal article
- review article
- Published by The Korean Society of Gastroenterology in The Korean Journal of Gastroenterology
- Vol. 81 (5) , 185-188
Abstract
Jung Wan Choe. Korean J Gastroenterol 2023;81:185-8. https://doi.org/10.4166/kjg.2023.042Keywords
This publication has 20 references indexed in Scilit:
- Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-AnalysisDisease Markers, 2015
- CA 19-9: handle with careClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status reportAnnals of Oncology, 2009
- M1046 How Do We Interpret An Elevated Carbohydrate Antigen 19-9 Level in Asymptomatic Subjects?Gastroenterology, 2008
- Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology, 2007
- Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients with Pancreatic CancerOncology, 2006
- The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing CholangitisDigestive Diseases and Sciences, 2005
- Clinical utility of biochemical markers in colorectal cancerEuropean Journal of Cancer, 2003
- Clinical Utility of the Serum CA 19-9 Test for Diagnosing Pancreatic Carcinoma in Symptomatic PatientsPancreas, 1992
- High Sensitivity and Specificity of CA 19-9 for Pancreatic Carcinoma in Comparison to Chronic Pancreatitis. Serological and Immunohistochemical FindingsPancreas, 1987